The treatment of JRA-associated uveitis with Etanercept. presented at the 2002.. (2002).
Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria is Not Endemic. Clinical and Vaccine Immunology, 17, 1552-1559. presented at the 10/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20702657. (2010).
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic. Clin Vaccine Immunol, 17(10), 1552-9. presented at the 2010 Oct. doi:10.1128/CVI.00082-10. (2010).
A Randomized, Placebo-Controlled, Double-Masked Clinical Trial of Etanercept for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Arthritis Rheum, 53, 18-23. presented at the 02/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15696578. (2005).
Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema. Retina, 30, 459-467. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20038863. (2010).
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis. Br J Ophthalmol, 87(1), 28-31. presented at the 2003 Jan. doi:10.1136/bjo.87.1.28. (2003).
A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis. Brit J Ophthalmol, 87, 28-31. presented at the 2003.. (2003).
The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study. Ophthalmology, 110, 1683-89. presented at the 2003.. (2003).
Longitudinal Clinical Findings and Outcome Among Cryptococcus gattii Patients in British Columbia. Clin Infect Dis, 60, 1368-1376. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25632012. (2015).
Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 49, 2696-2708. presented at the 06/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18515596. (2008).
Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease. presented at the 2004.. (2004).
Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina. Retina, 27, 150-158. presented at the 02/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17290195. (2007).
Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus. presented at the 2002.. (2002).
Horizontal rectus tenotomy in the treatment of Congenital Nystagmus (CN). presented at the 2001.. (2001).
Horizontal rectus tenotomy in patients with congenital nystagmus (CN): results in ten adults. Ophthalmology, 110, 2097-105. presented at the 2003.. (2003).
Evaluation of the Age-Related Eye Disease Study Clinical Lens Grading System AREDS Report No. 31. Ophthalmology, 117, 2112-2119.e3. presented at the 11/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20561686. (2010).
A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease. Ocul Immunol Inflamm, 15, 63-70. presented at the 03-04/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17558830. (2007).